{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:22:46Z","timestamp":1791408166432,"version":"4.3.3"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20212BDH81021"],"award-info":[{"award-number":["20212BDH81021"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019638","name":"Key Laboratory of Polysaccharide Bioactivity Evaluation of Traditional Chinese Medicine of Liaoning Province","doi-asserted-by":"publisher","award":["2024SSY06231"],"award-info":[{"award-number":["2024SSY06231"]}],"id":[{"id":"10.13039\/501100019638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014612","name":"Ningbo Institute of Materials Technology and Engineering CAS","doi-asserted-by":"publisher","award":["2021J036"],"award-info":[{"award-number":["2021J036"]}],"id":[{"id":"10.13039\/501100014612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32025021"],"award-info":[{"award-number":["32025021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012668","name":"National Synchrotron Radiation Laboratory","doi-asserted-by":"publisher","award":["2021-HLS-PT-004282"],"award-info":[{"award-number":["2021-HLS-PT-004282"]}],"id":[{"id":"10.13039\/501100012668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010033","name":"Soft Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2024QL026"],"award-info":[{"award-number":["2024QL026"]}],"id":[{"id":"10.13039\/501100010033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016082","name":"JiangXi Province Human Resources and Social Security Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010012","name":"National Aerospace Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.actbio.2024.07.033","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T12:02:19Z","timestamp":1721995339000},"page":"381-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damage"],"prefix":"10.1016","volume":"185","author":[{"given":"Zhouhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-7123","authenticated-orcid":false,"given":"Xuehua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-8923","authenticated-orcid":false,"given":"Aiguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2024.07.033_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2024.07.033_bib0002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2024.07.033_bib0003","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/cancers10070224","article-title":"Current molecular-targeted therapies in NSCLC and their mechanism of resistance","volume":"10","author":"Schrank","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2024.07.033_bib0004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2213-2600(22)00437-4","article-title":"Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.actbio.2024.07.033_bib0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s43018-023-00515-0","article-title":"ALK-positive lung cancer: a moving target","volume":"4","author":"Schneider","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.actbio.2024.07.033_bib0006","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s43018-022-00399-6","article-title":"Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer","volume":"3","author":"Shiba-Ishii","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.actbio.2024.07.033_bib0007","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer","volume":"6","author":"Gainor","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.actbio.2024.07.033_bib0008","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2024.07.033_bib0009","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(12)70344-3","article-title":"Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study","volume":"13","author":"Camidge","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.actbio.2024.07.033_bib0010","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.cllc.2016.05.003","article-title":"Challenges in facing the lung cancer epidemic and treating advanced disease in Latin America","volume":"18","author":"Raez","year":"2017","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.actbio.2024.07.033_bib0011","doi-asserted-by":"crossref","first-page":"e11171","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: what do we currently know?","volume":"8","author":"Pilotto Heming","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.actbio.2024.07.033_bib0012","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41598-018-19325-x","article-title":"Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells","volume":"8","author":"Nanayakkara","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2024.07.033_bib0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebiom.2015.12.009","article-title":"P-glycoprotein mediates ceritinib resistance in anaplastic lymphoma kinase-rearranged non-small cell lung cancer","volume":"3","author":"Katayama","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.actbio.2024.07.033_bib0014","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/ijc.28475","article-title":"Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar","volume":"134","author":"Tang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.actbio.2024.07.033_bib0015","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/0008-5472.CAN-18-2052","article-title":"Epithelial-to-mesenchymal transition is a mechanism of ALK inhibitor resistance in lung cancer independent of ALK mutation status","volume":"79","author":"Fukuda","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2024.07.033_bib0016","doi-asserted-by":"crossref","first-page":"38617","DOI":"10.1021\/acsami.2c12348","article-title":"Reducing chemo-\/radioresistance to boost the therapeutic efficacy against temozolomide-resistant glioblastoma","volume":"14","author":"Yun","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2024.07.033_bib0017","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1158\/0008-5472.CAN-20-1865","article-title":"Altered mitochondria functionality defines a metastatic cell state in lung cancer and creates an exploitable vulnerability","volume":"81","author":"Chuang","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2024.07.033_bib0018","first-page":"623","article-title":"Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via \u03b2-catenin\/c-Myc signaling pathway","volume":"13","author":"Wang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.actbio.2024.07.033_bib0019","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2024.07.033_bib0020","article-title":"Breaking iron homeostasis: iron capturing nanocomposites for combating bacterial biofilm","volume":"63","author":"Sun","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actbio.2024.07.033_bib0021","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.7150\/thno.20363","article-title":"Biodegradable core-shell dual-metal-organic-frameworks nanotheranostic agent for multiple imaging guided combination cancer therapy","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2024.07.033_bib0022","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1021\/ar900116g","article-title":"Synthesis, structure, and carbon dioxide capture properties of zeolitic imidazolate frameworks","volume":"43","author":"Phan","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.actbio.2024.07.033_bib0023","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcis.2023.04.126","article-title":"Enhanced lysosomal escape of cell penetrating peptide-functionalized metal-organic frameworks for co-delivery of survivin siRNA and oridonin","volume":"646","author":"Cai","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.actbio.2024.07.033_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000248","article-title":"The progress and prospect of zeolitic imidazolate frameworks in cancer therapy, antibacterial activity, and biomineralization","volume":"9","author":"Maleki","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2024.07.033_bib0025","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.7150\/thno.59593","article-title":"ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90","volume":"11","author":"Pan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2024.07.033_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.148590","article-title":"Dual-signal viscosity flow paper sensor for ATP detection based on bio-recognition and nanozyme activity regulation of ZIF-90","volume":"481","author":"Wang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2024.07.033_bib0027","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/ncomms4364","article-title":"ATP-triggered anticancer drug delivery","volume":"5","author":"Mo","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2024.07.033_bib0028","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1021\/jacs.7b01229","article-title":"Mitochondria targeted nanoscale zeolitic imidazole framework-90 for ATP imaging in live cells","volume":"139","author":"Deng","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2024.07.033_bib0029","article-title":"Mitochondrial-targeted copper delivery for cuproptosis-based synergistic cancer therapy","author":"Deng","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2024.07.033_bib0030","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1021\/acs.inorgchem.8b01316","article-title":"Diiodo-bodipy-encapsulated nanoscale metal-organic framework for ph-driven selective and mitochondria targeted photodynamic therapy","volume":"57","author":"Guan","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.actbio.2024.07.033_bib0031","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1039\/D3QM01020A","article-title":"Research advances and applications of ZIF-90 metal\u2013organic framework nanoparticles in the biomedical field","volume":"16","author":"Chen","year":"2024","journal-title":"Mater. Chem. Front."},{"key":"10.1016\/j.actbio.2024.07.033_bib0032","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/acs.nanolett.2c03784","article-title":"ROS-responsive nanoparticle delivery of mRNA and photosensitizer for combinatorial cancer therapy","volume":"23","author":"Zhou","year":"2023","journal-title":"Nano. Lett."},{"key":"10.1016\/j.actbio.2024.07.033_bib0033","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.7150\/thno.83745","article-title":"Near-infrared light-triggered nitric oxide nanocomposites for photodynamic\/photothermal complementary therapy against periodontal biofilm in an animal model","volume":"13","author":"Wu","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2024.07.033_bib0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-016-0285-5","article-title":"Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers","volume":"39","author":"Chen","year":"2016","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.actbio.2024.07.033_bib0035","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or evade multidrug resistance P-glycoprotein in cancer treatment","volume":"61","author":"Waghray","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actbio.2024.07.033_bib0036","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.apsb.2018.11.005","article-title":"Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting","volume":"9","author":"Zhou","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2024.07.033_bib0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2019.01.001","article-title":"Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo","volume":"197","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.07.033_bib0038","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.7150\/thno.39831","article-title":"Cooperation of endogenous and exogenous reactive oxygen species induced by zinc peroxide nanoparticles to enhance oxidative stress-based cancer therapy","volume":"9","author":"Lin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2024.07.033_bib0039","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41467-019-14199-7","article-title":"Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2024.07.033_bib0040","article-title":"Pathogen-activated macrophage membrane encapsulated CeO(2)-TCPP nanozyme with targeted and photo-enhanced antibacterial therapy","volume":"20","author":"Li","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.actbio.2024.07.033_bib0041","article-title":"Missing-linker-confined single-atomic Pt nanozymes for enzymatic theranostics of tumor","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actbio.2024.07.033_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303872","article-title":"Sonodynamic therapy of NRP2 monoclonal antibody-guided MOFs@COF targeted disruption of mitochondrial and endoplasmic reticulum homeostasis to induce autophagy-dependent ferroptosis","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2024.07.033_bib0043","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41467-022-32615-3","article-title":"Highly hydrated paramagnetic amorphous calcium carbonate nanoclusters as an MRI contrast agent","volume":"13","author":"Dong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2024.07.033_bib0044","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pnpbp.2018.12.015","article-title":"Mitochondrial function and abnormalities implicated in the pathogenesis of ASD","volume":"92","author":"Castora","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.actbio.2024.07.033_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.redox.2017.11.011","article-title":"Prolonged oxidative stress down-regulates early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis","volume":"14","author":"Armartmuntree","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.actbio.2024.07.033_bib0046","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41419-020-02757-7","article-title":"Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.actbio.2024.07.033_bib0047","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1600-0854.2009.00894.x","article-title":"Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis","volume":"10","author":"Eyster","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.actbio.2024.07.033_bib0048","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.actbio.2024.07.033_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.127610","article-title":"MOF-shielded and glucose-responsive ultrasmall silver nano-factory for highly-efficient anticancer and antibacterial therapy","volume":"416","author":"Li","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2024.07.033_bib0050","first-page":"18","article-title":"Black TiO(2) nanoprobe-mediated mild phototherapy reduces intracellular lipid levels in atherosclerotic foam cells via cholesterol regulation pathways instead of apoptosis","volume":"17","author":"Dai","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2024.07.033_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2020.100743","article-title":"MOF materials as therapeutic agents, drug carriers, imaging agents and biosensors in cancer biomedicine: recent advances and perspectives","volume":"117","author":"Bieniek","year":"2021","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.actbio.2024.07.033_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135369","article-title":"Plumbagin-loaded ZIF-90 nanoparticles suppress gastric cancer progression by targeting the YAP1 signaling","volume":"437","author":"Li","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2024.07.033_bib0053","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00604-021-04720-5","article-title":"Ultrasensitive electrochemical immunosensor based on the signal amplification strategy of the competitive reaction of Zn(2+) and ATP ions to construct a \"signal on\" mode GOx-HRP enzyme cascade reaction","volume":"188","author":"Li","year":"2021","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.actbio.2024.07.033_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100978","article-title":"Mitochondrial metabolism targeted nanoplatform for efficient triple-negative breast cancer combination therapy","volume":"10","author":"Lu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2024.07.033_bib0055","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2024.07.033_bib0056","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/21691401.2021.1884085","article-title":"CD44-targeted pH-responsive micelles for enhanced cellular internalization and intracellular on-demand release of doxorubicin","volume":"49","author":"Yang","year":"2021","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.actbio.2024.07.033_bib0057","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biomaterials.2016.01.060","article-title":"Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging","volume":"85","author":"Lee","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.07.033_bib0058","first-page":"312","article-title":"A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2024.07.033_bib0059","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actbio.2023.03.017","article-title":"Biomimetic nanoplatform with H(2)O(2) homeostasis disruption and oxidative stress amplification for enhanced chemodynamic therapy","volume":"162","author":"Fu","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2024.07.033_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122068","article-title":"Nrf2 silencing amplifies DNA photooxidative damage to activate the STING pathway for synergistic tumor immunotherapy","volume":"296","author":"Sun","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.07.033_bib0061","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/ijms22010412","article-title":"TUNEL assay: a powerful tool for kidney injury evaluation","volume":"22","author":"Moore","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2024.07.033_bib0062","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202305564","article-title":"Nanostructure-driven indocyanine green dimerization generates ultra-stable phototheranostics nanoparticles","volume":"62","author":"Kwon","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actbio.2024.07.033_bib0063","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3390\/ijms24032914","article-title":"Optimization of the hemolysis assay for the assessment of cytotoxicity","volume":"24","author":"S\u00e6b\u00f8","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124004021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124004021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:01:37Z","timestamp":1725793297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706124004021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":63,"alternative-id":["S1742706124004021"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2024.07.033","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damage","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2024.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}